Novartis, the Swiss drug manufacturer, has received the United States Food and Drug Administration’s (FDA) approval for Reclast, the first once-a-year treatment for osteoporosis, a disease that causes bones to break especially in postmenopausal women.
Discuss Add this link to... Tell a friendBury Add to:
| Bookmarks
Comments